{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Antibacterial agents",
      "Antiseptic",
      "Bacterial infection",
      "Bactericidal",
      "Pharyngitis",
      "Sore throat"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32093784",
  "DateCompleted": {
    "Year": "2020",
    "Month": "11",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "11",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "02",
        "Day": "24"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "99",
      "10.1186/s13104-020-04954-1"
    ],
    "Journal": {
      "ISSN": "1756-0500",
      "JournalIssue": {
        "Volume": "13",
        "Issue": "1",
        "PubDate": {
          "Year": "2020",
          "Month": "Feb",
          "Day": "24"
        }
      },
      "Title": "BMC research notes",
      "ISOAbbreviation": "BMC Res Notes"
    },
    "ArticleTitle": "Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat.",
    "Pagination": {
      "StartPage": "99",
      "MedlinePgn": "99"
    },
    "Abstract": {
      "AbstractText": [
        "For the majority of people with acute sore throat, over-the-counter treatments represent the primary option for symptomatic relief. This study evaluated the in vitro bactericidal activity of lozenges containing the antiseptic hexylresorcinol against five bacteria associated with acute sore throat: Staphylococcus aureus, Streptococcus pyogenes, Moraxella catarrhalis, Haemophilus influenzae and Fusobacterium necrophorum.",
        "Hexylresorcinol 2.4\u00a0mg lozenges were dissolved into 5\u00a0mL of artificial saliva medium. Inoculum cultures were prepared in triplicate for each test organism to give an approximate population of 10<sup>8</sup> colony-forming units (cfu)/mL. Bactericidal activity was measured by log reduction in cfu. Greater than 3log<sub>10</sub> reductions in cfu were observed at 1\u00a0min after dissolved hexylresorcinol lozenges were added to S. aureus (log<sub>10</sub> reduction cfu/mL\u2009\u00b1\u2009standard deviation, 3.3\u2009\u00b1\u20090.2), M. catarrhalis (4.7\u2009\u00b1\u20090.4), H. influenzae (5.8\u2009\u00b1\u20090.4) and F.\u00a0necrophorum (4.5\u2009\u00b1\u20090.2) and by 5\u00a0min for S. pyogenes (4.3\u2009\u00b1\u20090.4). Hexylresorcinol lozenges achieved a\u2009>\u200999.9% reduction in cfu against all tested organisms within 5\u00a0min, which is consistent with the duration for a lozenge to dissolve in the mouth. In conclusion, in vitro data indicate that hexylresorcinol lozenges offer rapid bactericidal activity against organisms implicated in acute sore throat."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-5898-1417"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Reckitt Benckiser Healthcare International Ltd, 103-105 Bath Road, Slough, Berkshire, SL1 3UH, UK. derek.matthews@rb.com."
          }
        ],
        "LastName": "Matthews",
        "ForeName": "Derek",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Reckitt Benckiser Healthcare UK Ltd, Dansom Lane, Hull, HU8 7DS, UK."
          }
        ],
        "LastName": "Adegoke",
        "ForeName": "Oluwajoba",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Reckitt Benckiser Healthcare International Ltd, 103-105 Bath Road, Slough, Berkshire, SL1 3UH, UK."
          }
        ],
        "LastName": "Shephard",
        "ForeName": "Adrian",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "BMC Res Notes",
    "NlmUniqueID": "101462768",
    "ISSNLinking": "1756-0500"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents, Local"
    },
    {
      "RegistryNumber": "R9QTB5E82N",
      "NameOfSubstance": "Hexylresorcinol"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Oral"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Infective Agents, Local"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Bacterial Infections"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Bacterial Load"
    },
    {
      "QualifierName": [
        "drug therapy",
        "microbiology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Fusobacterium necrophorum"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Haemophilus influenzae"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Hexylresorcinol"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Microbial Sensitivity Tests"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Moraxella catarrhalis"
    },
    {
      "QualifierName": [
        "drug effects",
        "microbiology"
      ],
      "DescriptorName": "Oropharynx"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Staphylococcus aureus"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "Streptococcus pyogenes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Time Factors"
    }
  ],
  "CoiStatement": "DM, OA and AS are employees of Reckitt Benckiser Healthcare Ltd, UK."
}